6 employees
Scil Proteins, a biopharmaceutical company, discovers and develops Affilin molecules for manufacturing protein therapeutics and diagnostics.
1999
$33M
from 1 investors over 1 rounds
Scil Proteins GmbH raised $33M on February 2, 2011
Investors: BioNet Holding GmbH